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Abstract
Objective: To assess the quality of life of patients with lung cancer and to compare it with that of individuals without cancer. Methods: The 
Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) was administered to 57 patients diagnosed with lung cancer, treated 
at the Lung Cancer Outpatient Clinic of the Hospital São Paulo, and to a control group of 57 individuals recruited from the Extra Penha 
workout group. The Mann-Whitney test was used to compare the groups, domain by domain. The first model of logistic regression was 
adjusted for male gender, nonsurgical treatment, Karnofsky performance status and smoking, which were included as predictors. The second 
model was adjusted for each SF-36 domain in order to identify increases in the proportions of patients in stage IIIB or IV. Results: The lung 
cancer group and the control group presented the following mean scores, respectively, for the SF-36 domains: role limitations due to physical 
health problems, 29.39 ± 36.94 and 82.89 ± 28.80; role limitations due to emotional problems, 42.78 ± 44.78 and 86.55 ± 28.77; physical 
function, 56.49 ± 28.39 and 89.00 ± 13.80; vitality, 61.61 ± 23.82 and 79.12 ± 17.68; bodily pain, 62.72 ± 28.72 and 81.54 ± 19.07; general 
health, 62.51 ± 25.57 and 84.47 ± 13.47; emotional well-being, 68.28 ± 23.46 and 82.63 ± 17.44; and social functioning, 72.87 ± 29.20 and 
91.67 ± 17.44. The logistic regression model showed that role limitations due to physical health problems, physical function and emotional 
well-being were predictors of stages IIIB and IV. Conclusion: The patients with lung cancer had a poorer quality of life, especially regarding 
physical aspects, than did the control subjects.
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Resumo
Objetivo: Avaliar a qualidade de vida de pacientes com câncer de pulmão e compará-la com a qualidade de vida de indivíduos sem câncer. 
Métodos: O questionário Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) foi aplicado em 57 pacientes com diagnóstico 
de câncer de pulmão provenientes do Ambulatório de Oncopneumologia do Hospital São Paulo e em um grupo controle de 57 indivíduos 
participantes do Grupo de Ginástica Extra Penha. O teste de Mann-Whitney foi utilizado para comparar cada domínio entre os grupos. O 
primeiro modelo de regressão logística foi ajustado para sexo masculino, tratamento não cirúrgico, índice de Karnofsky e tabagismo, que 
foram incluídos como preditores. O segundo modelo foi ajustado para cada domínio do SF-36 para identificar aumento na proporção de 
estádios IIIB e IV. Resultados: O grupo com câncer de pulmão e o grupo controle apresentaram, respectivamente, as seguintes pontuações 
médias para os domínios do SF-36: aspectos físicos, 29,39 ± 36,94 e 82,89 ± 28,80; aspectos emocionais, 42,78 ± 44,78 e 86,55 ± 28,77; 
capacidade funcional, 56,49 ± 28,39 e 89,00 ± 13,80; vitalidade, 61,61 ± 23,82 e 79,12 ± 17,68; dor, 62,72 ± 28,72 e 81,54 ± 19,07; 
estado geral de saúde, 62,51 ± 25,57 e 84,47 ± 13,47; saúde mental, 68,28 ± 23,46 e 82,63 ± 17,44; e aspectos sociais, 72,87 ± 29,20 e 
91,67 ± 17,44. O modelo de regressão logística demonstrou que aspectos físicos, capacidade funcional e saúde mental foram preditores de 
estádios IIIB e IV. Conclusões: Os pacientes com câncer de pulmão apresentaram pior qualidade de vida em relação ao grupo controle, 
principalmente em relação aos aspectos físicos.
Descritores: Neoplasias pulmonares; Qualidade de vida; Nível de saúde.
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by the same professional in the morning of the day 
of their workout session, prior to the beginning of 
their activities. The data collection process included 
the following:
•	An	evaluation	chart	containing	personal	data	
and information related to comorbidities, 
respiratory symptoms, smoking habit, as well 
as, in the case of patients with lung cancer, 
previous history of cancer and treatment. 
•	Data	 regarding	 cancer:	 Karnofsky	 perform-
ance status, staging and histological type of 
tumor. The tumor-node-metastasis staging 
was conducted in accordance with the guide-
lines established by the International System 
for Staging Lung Cancer.(8)
•	Assessment	of	the	quality	of	life	of	patients	by	
means of the Medical Outcomes Study 36-item 
Short-Form Health Survey (SF-36), which is a 
generic, multidimensional, reliable and easily 
administered questionnaire. The SF-36 has 
been translated, adapted and validated for use 
in Brazil.(9) 
The SF-36 questionnaire comprises eight 
domains (subscales):
1) The physical function domain assesses the 
incidence and extent of limitations in physical 
capacity.
2) The role limitations due to physical health 
problems domain assesses limitations regarding 
the type and quality of work, as well as to what 
extent such limitations impair work perform-
ance and activities of daily living.
3) The bodily pain domain assesses the incidence 
and the intensity of physical pain, as well as 
to what extent such pain interferes with the 
ability to perform activities of daily living. 
4) The general health domain evaluates how 
patients feel regarding their overall health.
5) The vitality domain evaluates aspects related to 
energy level and fatigue.
6) The social functioning domain assesses the inte-
gration of the individual in social activities.
7) The role limitations due to emotional problems 
domain assesses the impact of psychological 
aspects on the well-being of the patient. 
8) The emotional well-being domain includes 
questions related to anxiety, depression, 
behavioral changes, emotional stability and 
psychological well-being.
Introduction
Characterizing quality of life has become one of 
the main objectives in the assessment of patients 
with cancer in general. This increasing interest is 
due to the fact that quality of life has become more 
highly valued than is quantity of life for individuals 
with limiting or incapacitating conditions.(1)
According to the World Health Organization, 
quality of life is the perception that the individual 
has regarding his/her present life situation, including 
his/her objectives, expectations, patterns and preoc-
cupations.(2) Therefore, quality of life encompasses 
not only aspects related to health, but also those 
that have an influence on it, such as social, cultural 
and economic aspects.(3)
Lung cancer is one of the most prevalent 
tumors and is responsible for high mortality rates 
worldwide.(4) The quality of life of these patients 
is affected by various factors, such as the stage of 
the disease, treatment characteristics and aspects 
related to each individual.(5) However, regardless 
of these factors, the initial quality of life is a rele-
vant measure for the assessment of prognosis and 
survival.(6,7)
Therefore, the objective of this study was to 
assess the quality of life of patients with lung cancer, 
comparing it to that of a control group (individuals 
without cancer), and to identify the aspects that 
caused greater limitations, as well as determining 
the influence that clinical parameters have on this 
measure.
Methods
This was a prospective, cross-sectional study 
including patients with confirmed lung cancer and 
treated at the Lung Cancer Outpatient Clinic of the 
Federal University of São Paulo Hospital São Paulo. 
Individuals without cancer, recruited from the Extra 
Penha workout group, were included in the control 
group.
This protocol was previously approved by the 
Ethics in Clinical Research Committee of the São 
Camilo University Center.
The selected patients were evaluated on the day 
of their outpatient medical visit and were inter-
viewed individually to determine whether or not 
they could be considered clinically stable. All inter-
views were carried out by the same professional. 
Individuals in the control group were interviewed 
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undifferentiated small cell lung cancer was carried 
out by means of logistic regression analysis in order 
to determine significant differences in the clinical 
variables in the first model, as well as in the SF-36 
domains in the second model. The following inde-
pendent exposure variables were included in the 
first model: male gender (reference group: female 
gender); histological type: adenocarcinoma, catego-
rized by the non-adenocarcinoma reference group; 
Karnofsky performance status as a continuous vari-
able; and smokers (reference group: nonsmokers). 
In the second logistic regression model, we used as 
independent variables the following domains: phys-
ical function, role limitations due to physical health 
The SF-36 scores range from 0 to 100, obtained 
from a list of questions on various aspects related to 
quality of life. Higher scores indicate better quality 
of life.(10,11)
In the statistical analysis, results were expressed 
as means, standard deviations and proportions. We 
used the following tests to compare the two groups: 
the chi-square test to compare categorical vari-
ables, the Student’s t-test to compare parametric 
continuous variables and the Mann-Whitney test 
to compare non-parametric continuous variables.(12) 
The comparison between the group with advanced 
staging (IIIB and IV) and the reference group (from 
IA to IIIA) with localized form of the disease for 
Table 1 - Characteristics of the individuals in both groups, together with characteristics of histological type, staging 
and treatment of individuals in the lung cancer group.
Variable Lung cancer Control p
Age (years), mean ± SD 61.3 ± 16.4 60.0 ± 12.2 ns*
Male gender, n (%) 32 (56.1%) 23 (40.4%) ns*
Smoking habit - - ns*
Smokers, n (%) 3 (5.3%) 2 (3.5%) -
Former smokers, n (%) 44 (77.2%) 17 (29.8%) -
Nonsmokers, n (%) 10 (17.5%) 38 (66.7%) -
Tobacco intake (pack-years), mean ± SD 56.5 ± 40.1 11.4 ± 12.3 <0.0001**
Histological type - - -
Adenocarcinoma, n (%) 27 (47.4%) - -
SCC, n (%) 19 (33.3%) - -
SCLC, n (%) 3 (5.3%) - -
Other, n (%) 8 (14.0%) - -
Karnofsky performance status, mean ± SD 90.4 ± 9.8 - -
Staging - - -
IA, n (%) 7 (12.3%) - -
IB, n (%) 8 (14.0%) - -
IIB, n (%) 3 (5.3%) - -
IIIA, n (%) 9 (15.8%) - -
IIIB, n (%) 12 (21.1%) - -
IV, n (%) 11 (19.2%) - -
Limited (SCLC), n (%) 2 (5.3%) - -
No staging, n (%) 4 (7.0%) - -
Treatment - - -
Chemotherapy, n (%) 22 (38.5%) - -
Surgery, n (%) 9 (15.7%) - -
Surgery + adjutant treatment, n (%) 15 (26.3%) - -
Chemotherapy + radiotherapy, n (%) 5 (8.8%) - -
No treatment, n (%) 6 (10.7%) - -
SD: standard deviation; ns: not significant; SCC: spinocellular carcinoma; and SCLC: small cell lung cancer. *chi-square test. 
**Student’s t-test.
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The patients with lung cancer presented with 
the following respiratory symptoms: 54% reported 
dyspnea, 30% reported fatigue, and 16% reported 
cough. Individuals in the control group reported no 
respiratory symptoms.
After being adjusted for male gender, adenocar-
cinoma, Karnofsky performance status and smoking, 
the first logistic regression model, which included 
clinical variables, revealed no significant association 
with the lung cancer stages IIIB or IV (Table 3). 
As can be seen in Table 4 and Figure 1, the second 
adjusted logistic regression model revealed that the 
domains physical function, role limitations due to 
physical health problems and emotional well-being 
presented significant associations with the more 
advanced stages of lung cancer (IIIB and IV). 
Discussion
All of the SF-36 quality of life domains were 
negatively affected by lung cancer. Differences of 
more than five points, which can be interpreted 
as clinically and socially significant,(13) were found 
between the study group and the control group. All 
of these domains represent fundamental aspects of 
the autonomy of individuals regarding their ability 
to perform activities of daily living. The domains 
role limitations due to physical health prob-
lems, physical function and emotional well-being 
presented statistically significant associations with 
the more advanced stages of the disease. Therefore, 
lower scores in the domains physical function and 
role limitations due to physical health problems, as 
well as higher scores in the emotional well-being 
domain, increased the probability of presenting the 
more advanced stages of the disease. 
problems, bodily pain, general health, role limita-
tions due to emotional problems and emotional 
well-being, all from the SF-36. Statistical analyses 
were carried out using the Statistical Package for 
the Social Sciences, version 13.0 (SPSS Inc., Chicago, 
IL, USA). All statistical tests were two-tailed, and the 
level of significance was set at 5%.
Results
In total, 114 individuals agreed to participate 
in the study: 57 in the control group and 57 in 
the group diagnosed with lung cancer. The basic 
characteristics of the individuals in both groups, as 
well as the characteristics related to lung cancer, are 
described in Table 1.
No differences were found between the 
groups regarding age, gender or smoking habit, 
although the control group had a greater number 
of nonsmokers (66.7%), whereas the study group 
had a greater number of former smokers (77.2%). 
Tobacco intake in pack-years was statistically higher 
among patients with lung cancer than among indi-
viduals in the control group.
In our sample, distribution regarding histological 
type of cancer showed a predominance of adeno-
carcinoma (47.4%) and spinocellular carcinoma 
(33.3%). In addition, as expected, the majority 
of the cases (56.2%) presented locally advanced 
staging of the disease.
Table 2 summarizes the quality of life scores 
for both groups, by SF-36 domain. The patients 
with lung cancer had lower scores in all of the 
SF-36 domains than did the individuals in the 
control group, and the differences were statistically 
significant.
Table 2 - Scores in the Medical Outcomes Study 36-item Short-Form Health Survey domains, by group.
Domain Lung cancer group Control group p*
PF, mean ± SD 56.49 ± 28.39 89.00 ± 13.80  <0.0001
RLP, mean ± SD 29.39 ± 36.94 82.89 ± 28.80  <0.0001
GH, mean ± SD 62.51 ± 25.57 84.47 ± 13.47  <0.0001
V, mean ± SD 61.61 ± 23.82 79.12 ± 17.68  <0.0001
RLE, mean ± SD 42.78 ± 44.78 86.55 ± 28.77  <0.0001
BP, mean ± SD 62.72 ± 28.72 81.54 ± 19.07  <0.0001
EWB, mean ± SD 68.28 ± 23.46 82.63 ± 17.44  <0.0001
SF, mean ± SD 72.87 ± 29.20 91.67 ± 17.44  <0.0001
PF: physical function; SD: standard deviation; RLP: role limitations due to physical health problems; GH: general health; V: vitality; 
RLE: role limitations due to emotional problems; BP: bodily pain; EWB: emotional well-being; and SF: social functioning. *Mann-
Whitney test.
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In this study, the second worse score in the 
group with lung cancer was found in role limita-
tions due to emotional problems, which assesses 
the impact of psychological aspects on the well-
being of the patient. The decreased scores of these 
aspects might have been due to the impact of the 
diagnosis of cancer and fear of death. The patients 
suffer not only from physical symptoms but also 
from a life crisis due to their impending death, 
since these patients are commonly diagnosed with 
depression, especially those with advanced disease 
and functional limitations.(21-23) However, a relation-
ship between this domain and advanced stages of 
the disease, by means of the analysis of the logistic 
regression model, was not found in the present 
study.
The emotional well-being domain, which 
includes questions on anxiety, depression, changes in 
behavior, lack of emotional control and psycholog-
ical well-being, also showed a significant difference 
between the study and control groups. The impact 
of cancer on emotional well-being showed that 
the diagnosis and treatment can be accompanied 
by anxiety and depression.(24,25) Curiously, in the 
logistic regression analysis of our study, the scores 
of patients in the more advanced stages of lung 
cancer in the emotional well-being domain were 
slightly higher than those of other patients, possibly 
indicating better acceptance of the diagnosis of 
cancer or the comforting effect of the adjuvant care 
offered to patients in the more advanced stages of 
the disease.
The incidence of pain was also higher in the 
group with cancer. A common cause for greater 
pain is advanced staging, with which most of the 
patients included in this study presented. However, 
this association was not found in the logistic regres-
sion model.
General health assesses how the patient feels 
regarding his/her global health. Although the scores 
of this domain were also decreased in the patients 
with lung cancer when compared to the control 
group, no correlation with more advanced stages of 
the disease was found.
The patients with lung cancer presented 
lower scores in the social functioning and vitality 
domains. However, these scores were the closest to 
normal limits.(18) Patients with severe, potentially 
fatal diseases probably receive greater support from 
According to the logistic regression analysis, the 
clinical variables under study (gender, histological 
type, performance status and smoking) showed no 
relationship with the more advanced stages of the 
disease. Except for Karnofsky performance status, 
none of the clinical variables that were included in 
the model are typical predictors of severity.
Various for the assessment of quality of life and 
of the functional status of patients with cancer have 
been available. The SF-36 is a generic instrument 
that can help assess the quality of life of individ-
uals with a wide range of diseases. Various authors 
consider the SF-36 a useful questionnaire for the 
assessment of quality of life in patients with lung 
cancer.(14-17) In addition, the SF-36 combines good 
psychometric properties and good responsiveness, 
as well as being better able to detect worsening 
than improvement in quality of life.(18)
Role limitations due to physical health prob-
lems showed the lowest scores when compared 
to all of the SF-36 domains, even in the control 
group. These low scores might be related to reduced 
pulmonary function and dyspnea upon exertion.
(19) Although we did not use a scale to quantify 
dyspnea, it was reported by 54% of the patients 
with lung cancer, and this fact contributed to the 
worsening of quality of life, since dyspnea limits the 
ability to perform activities of daily living and to 
work. However, nonphysical factors, related to diffi-
culties to carry out work and domestic activities, 
might have contributed to the worsening of quality 
of life of patients with lung cancer.(20) 
The physical function domain, which encom-
passes the incidence and the extent of limitations 
due to physical capacity, showed the same trend 
toward lower scores seen in the group with lung 
cancer.
Table 3 - Adjusted logistic regression model for male 
gender, adenocarcinoma, Karnofsky performance status 
and smoking in patients in the advanced stages (IIIB or 
IV) of lung cancer (n = 57).
Variable Odds ratio 95% CI p
Male gender 3.24 0.94-11.24 0.06
Adenocarcinoma 1.67 0.49-5.70 0.41
Karnofsky 
performance status
0.99 0.93-1.05 0.69
Smoking 0.60 0.28-1.33 0.21
CI: confidence interval.
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on a regular basis, which is known to be a factor 
related to better quality of life.(27) However, the rela-
tionship between physical activity and improved 
quality of life has a limited effect in elderly people, 
depending on individual factors and variations in 
the responses.(28,29) The SF-36 scores of the control 
group are similar to the normal scores described by 
Bouchet et al.(18)
The incidence, number and intensity of 
comorbidities can influence the quality of life of 
individuals. However, this was not specifically 
studied in our sample. Nevertheless, our patients 
presented good Karnofsky performance status (≥70), 
and the individuals in the control group practiced 
physical activities, probably without any limiting 
comorbidities.
We concluded that the individuals with lung 
cancer had a poorer quality of life than did those 
without cancer. Therefore, the SF-36 proved to be a 
useful instrument for comparing these two groups 
in terms of their quality of life. 
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